Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Hana Biosciences

Request full access

Biopharmaceutical company developing and commercializing differentiated cancer therapies

San Francisco, United StatesBiotech & Life Sciences

About Hana Biosciences

Hana Biosciences is a pharmaceutical company dedicated to developing effective cancer therapies. Operating in the oncology sector, the company focuses on creating innovative solutions for the diagnosis, treatment, and prevention of various cancers. Hana Biosciences serves healthcare providers and patients who are in need of advanced cancer treatments. The company operates in the highly specialized market of bioscience pharmaceuticals, where precision equipment and cutting-edge research are essential for eliminating cancerous cells.

The business model of Hana Biosciences involves extensive research and development (R&D) to create new cancer therapies, which are then brought to market through clinical trials and regulatory approvals. Revenue is generated through the sale of these therapies to hospitals, clinics, and healthcare providers. Additionally, the company may engage in partnerships and collaborations with other pharmaceutical firms to expand its reach and capabilities.

Hana Biosciences makes money primarily through the commercialization of its cancer treatment products, licensing agreements, and potential milestone payments from collaborative ventures.

Source: Dealroom company data

At a glance

Status
Closed
Open positions
None listed
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS
Business model
Manufacturing
Client focus
B2B
Links
Website

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GROWTH EQUITY VCOther financing Jun 2010 $100M — Warburg Pincus —
LATE VCOther financing Oct 2009 $16M $65M Undisclosed —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
CaroCure Discovery Solutions Private LimitedPreclinical drug discovery cro that uses computational chemistry and ai to develop new drugs and cosmetics Hyderabad, India Operational 1 $700K —
Contraria BiotechDevelops innovative, cost-effective therapeutic and prophylactic drugs to combat global health challenges like antibiotic resistance, emerging diseases, and pandemics Siena, Italy Operational
Synkrino BiotherapeuticsLeverages deep industry experience and technical expertise to pinpoint early-stage ventures in under-served healthcare sectors where significant ongoing support can maximize efficiencies and produce superior returns St. Louis, United States Operational
Ochre BioDevelops RNA therapies for chronic liver diseases, a leading cause of death globally Oxford, United Kingdom Operational
BigHat BiosciencesProtein therapeutics company that develops an antibody design platform guided by artificial intelligence San Carlos, United States Operational
XilisDeveloping next generation technologies for precision medicine and drug discovery Durham, United States Operational
MindRank AIMindRank AI is a developer of proprietary end-to-end AI-driven drug-discovery platform (Molecule Pro™) Hangzhou, China Operational
Rosa BiotechAI-driven biosensing and diagnostics company providing outcome-focused biosensing for early disease diagnosis and for use in industrial biotechnology Bristol, United Kingdom Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Hana Biosciences in the San Francisco ecosystem

Live from Dealroom

The Hana Biosciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · San Francisco HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Hana Biosciences on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Hana Biosciences’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.